Kaneka Corporation Share Price

Equities

4118

JP3215800008

Commodity Chemicals

Market Closed - Japan Exchange 07:00:00 26/04/2024 BST 5-day change 1st Jan Change
3,990 JPY +1.40% Intraday chart for Kaneka Corporation +2.57% +11.39%

Financials

Sales 2024 * 768B 4.85B 388B Sales 2025 * 801B 5.06B 405B Capitalization 258B 1.63B 130B
Net income 2024 * 22.72B 143M 11.49B Net income 2025 * 24.73B 156M 12.5B EV / Sales 2024 * 0.5 x
Net Debt 2024 * 127B 804M 64.38B Net Debt 2025 * 133B 842M 67.41B EV / Sales 2025 * 0.49 x
P/E ratio 2024 *
11.4 x
P/E ratio 2025 *
10.3 x
Employees 11,545
Yield 2024 *
2.76%
Yield 2025 *
2.93%
Free-Float 87.41%
More Fundamentals * Assessed data
Dynamic Chart
Sony Corporation Adopts Kaneka Corporation's Foam Molded Product Made from Kaneka Biodegradable Polymer Green Planet as A Cushioning Material for Its Large-Screen Televisions CI
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on February 8, 2024. CI
Kaneka Corporation announces an Equity Buyback for 2,000,000 shares, representing 3.08% for ¥8,000 million. CI
Kaneka Corporation authorizes a Buyback Plan. CI
Kaneka Corporation acquired Japan Medical Device Technology Co., Ltd. CI
Sun-Novo Pharma Gets License to Produce Kaneka’s Transdermal Patches MT
Kaneka Corporation Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on September 9, 2022. CI
Kaneka Corporation's Equity Buyback announced on September 9, 2022 has closed with 2,300,000 shares, representing 3.47% for ¥8,042.21 million. CI
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on September 9, 2022. CI
Kaneka Corporation Announces Manufacture and Supply Intermediates to Shionogi & Co., Ltd for Use in Xocova® CI
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on September 9, 2022. CI
Kaneka Corporation announces an Equity Buyback for 2,300,000 shares, representing 3.42% for ¥10,000 million. CI
Kaneka Corporation authorizes a Buyback Plan. CI
Kaneka Corporation agreed to acquire remaining 45.24% stake in Cemedine Co., Ltd.. CI
More news
1 day+1.40%
1 week+2.57%
Current month+4.61%
1 month+2.84%
3 months+11.48%
6 months+6.49%
Current year+11.39%
More quotes
1 week
3 907.00
Extreme 3907
4 050.00
1 month
3 752.00
Extreme 3752
4 056.00
Current year
3 522.00
Extreme 3522
4 056.00
1 year
3 456.00
Extreme 3456
4 288.00
3 years
3 165.00
Extreme 3165
4 990.00
5 years
2 112.00
Extreme 2112
5 000.00
10 years
2 112.00
Extreme 2112
6 390.00
More quotes
Managers TitleAgeSince
President 62 31/03/85
Chairman 77 01/04/70
Director/Board Member 64 31/03/87
Members of the board TitleAgeSince
Chairman 77 01/04/70
Director/Board Member 64 31/03/87
Corporate Officer/Principal 67 31/03/81
More insiders
Date Price Change Volume
26/04/24 3,990 +1.40% 309,100
25/04/24 3,935 -0.78% 118,800
24/04/24 3,966 -1.00% 226,300
23/04/24 4,006 +0.93% 281,500
22/04/24 3,969 +2.03% 128,600

Delayed Quote Japan Exchange, April 26, 2024 at 07:00 am

More quotes
KANEKA CORPORATION is a Japan-based company engaged in four business segments. The Material Solutions Unit segment includes general purpose vinyl chloride resin, caustic soda, polyvinyl chloride special resin, modifier, modified silicone polymer, biodegradable polymer. Quality of Life Solutions Unit segment includes expanded styrene resin and molded products, extruded polystyrene foam boards, bead method expanded polyolefin, solar circuit method, super heat resistant polyimide films, optical materials, super heat conductive graphite sheets, solar cells, storage batteries for housing and others. The Health Care Solutions Unit segment includes medical devices, low molecular weight pharmaceutical raw materials, biopharmaceuticals, etc. The Nutrition Solutions Unit segment includes functional food ingredients, margarine, shortening, baker's yeast, spices, antifreeze ingredients, functional fertilizers and feeds.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
3,990 JPY
Average target price
4,091 JPY
Spread / Average Target
+2.54%
Consensus